It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...

An age-old question about which came first, the chicken or the egg, won't matter for a biotech startup that aims to make egg protein powder – used in baked goods and other foods – from ...

AbbVie (NYSE: ABBV) in partnership with the University of Toronto's SpinUp, are pleased to announce Neuropeutics Inc as the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by ...

ProteinQure raises $11M Series A led by Heron Rock to advance PQ203, a peptide-drug conjugate for triple-negative breast ...

In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

Cvictus recently received a $1.7 million grant from the Bill & Melinda Gates Foundation to scale its technology.

At the recent F&A Next conference in Wageningen, the Feike Sijbesma Sustainable Innovation Award 2025 was granted to two ...

Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has identified radiolabeled or nonradiolabeled compounds acting as fibroblast activation protein-α (FAPα) inhibitors reported to be useful for the ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...